CIK: 0001566787
Total reported value
$24.6M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RPRX | Royalty Pharma plc | Stock-Healthcare | 71.84% | — | — | |
| 2 | GDX | Vaneck Gold Miners ETF | ETF-Commodities | 16.41% | — | — | |
| 3 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 6.97% | — | — | |
| 4 | YMABUSD | Y-mabs Therapeutics INC | Stock-Other | 4.79% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GDX | Vaneck Gold Miners ETF | +1.6% | — | Unchanged |
| 2 | YMABUSD | Y-mabs Therapeutics INC | +0.8% | — | Unchanged |
| 3 | RPRX | Royalty Pharma plc | -0.2% | — | Unchanged |
| 4 | ORIC | Oric Pharmaceuticals INC | -2.1% | — | Unchanged |